16/06/2020 (Agence Europe) – Germany will invest 300 million euros in the company CureVac to support the development of a vaccine against Covid-19, Federal Economics Minister Peter Altmaier announced on 15 June. This investment “aims to ensure that the company is not taken over by a foreign investor and that it does not leave the country”, says a letter from the German Ministry unveiled by the Financial Times. And this at a time when the company was planning an IPO on the Nasdaq in mid-July and rumours were circulating in mid-March about American ambitions. “It is feared that in the event of a takeover and migration abroad, a Covid-19 vaccine developed by CureVac will not be made available to Germany and the EU”, the document continues. This amount complements an EU guarantee of 80 million euros (see EUROPE 12447/1). As of June 9, there were 10 vaccine candidates in the clinical stage and 126 in the preclinical stage. (SPj)